{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T05:56:11Z","timestamp":1774418171334,"version":"3.50.1"},"reference-count":45,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["NS111619"],"award-info":[{"award-number":["NS111619"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jpet.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1124\/jpet.124.002334","type":"journal-article","created":{"date-parts":[[2024,10,23]],"date-time":"2024-10-23T19:50:14Z","timestamp":1729713014000},"page":"100046","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Clinical development of the GluN2B-selective NMDA receptor inhibitor NP10679 for the treatment of neurologic deficit after subarachnoid hemorrhage"],"prefix":"10.1016","volume":"392","author":[{"given":"Haichen","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raymond J.","family":"Dingledine","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6689-3978","authenticated-orcid":false,"given":"Scott J.","family":"Myers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3750-9615","authenticated-orcid":false,"given":"Stephen F.","family":"Traynelis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chuan","family":"Fang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanli","family":"Tan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"George W.","family":"Koszalka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel T.","family":"Laskowitz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1124\/jpet.124.002334_bib1","doi-asserted-by":"crossref","first-page":"2673","DOI":"10.1001\/jama.286.21.2673","article-title":"Aptiganel hydrochloride in acute ischemic stroke: a randomized controlled trial","volume":"286","author":"Albers","year":"2001","journal-title":"JAMA"},{"key":"10.1124\/jpet.124.002334_bib2","first-page":"133","article-title":"Antagonizing excitotoxicity: a therapeutic strategy for stroke?","volume":"65","author":"Choi","year":"1998","journal-title":"Mt Sinai J Med"},{"key":"10.1124\/jpet.124.002334_bib48","series-title":"Guide for the Care and Use of Research Animals: Eighth Edition","year":"2011"},{"key":"10.1124\/jpet.124.002334_bib5","first-page":"101","article-title":"Lessons from epidemiologic studies in clinical trials of traumatic brain injury","volume":"89","author":"Farin","year":"2004","journal-title":"Acta Neurochir"},{"key":"10.1124\/jpet.124.002334_bib6","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/0006-8993(90)91276-M","article-title":"Acidosis reduces NMDA receptor activation, glutamate neurotoxicity, and oxygen-glucose deprivation neuronal injury in cortical cultures","volume":"506","author":"Giffard","year":"1990","journal-title":"Brain Res"},{"key":"10.1124\/jpet.124.002334_bib7","doi-asserted-by":"crossref","first-page":"2123","DOI":"10.1161\/01.STR.0000025518.34157.51","article-title":"Toward wisdom from failure: lessons from neuroprotective stroke trials and new therapeutic directions","volume":"33","author":"Gladstone","year":"2002","journal-title":"Stroke"},{"key":"10.1124\/jpet.124.002334_bib8","series-title":"Institute of Laboratory Animal Resources","year":"2011"},{"key":"10.1124\/jpet.124.002334_bib9","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1007\/s11883-008-0054-7","article-title":"Management of post-subarachnoid hemorrhage vasospasm","volume":"10","author":"Gump","year":"2008","journal-title":"Curr Atheroscler Rep"},{"key":"10.1124\/jpet.124.002334_bib10","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/nn835","article-title":"Extrasynaptic NMDARs oppose synaptic NMDARs by triggering CREB shut-off and cell death pathways","volume":"5","author":"Hardingham","year":"2002","journal-title":"Nat Neurosci"},{"key":"10.1124\/jpet.124.002334_bib11","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1021\/acschemneuro.2c00779","article-title":"Novel GluN2B-selective NMDA receptor negative allosteric modulator possesses intrinsic analgesic properties and enhances analgesia of morphine in a rodent tail flick pain model","volume":"14","author":"Harris","year":"2023","journal-title":"ACS Chem Neurosci"},{"key":"10.1124\/jpet.124.002334_bib12","doi-asserted-by":"crossref","first-page":"10229","DOI":"10.1073\/pnas.1902647116","article-title":"Endothelial NMDA receptors mediate activity-dependent brain hemodynamic responses in mice","volume":"116","author":"Hogan-Cann","year":"2019","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1124\/jpet.124.002334_bib13","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1111\/j.1460-9568.1992.tb00863.x","article-title":"Extra- and intracellular pH in the brain during ischaemia, related to tissue lactate content in normo- and hypercapnic rats","volume":"4","author":"Katsura","year":"1992","journal-title":"Eur J Neurosci"},{"key":"10.1124\/jpet.124.002334_bib14","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1038\/nn936","article-title":"NMDA receptor pathways as drug targets","volume":"5","author":"Kemp","year":"2002","journal-title":"Nat Neurosci"},{"key":"10.1124\/jpet.124.002334_bib15","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1186\/s12987-022-00364-6","article-title":"Activation of NMDA receptors in brain endothelial cells increases transcellular permeability","volume":"19","author":"Kim","year":"2022","journal-title":"Fluids Barriers CNS"},{"key":"10.1124\/jpet.124.002334_bib16","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S0006-3223(96)00047-9","article-title":"Psychotogenicity and N-methyl-D-aspartate receptor antagonism: implications for neuroprotective pharmacotherapy","volume":"41","author":"Kornhuber","year":"1997","journal-title":"Biol Psychiatry"},{"key":"10.1124\/jpet.124.002334_bib17","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1161\/01.STR.27.4.625","article-title":"Incidence of subarachnoid hemorrhage: role of region, year, and rate of computed tomography: a meta-analysis","volume":"27","author":"Linn","year":"1996","journal-title":"Stroke"},{"key":"10.1124\/jpet.124.002334_bib18","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1136\/svn-2018-000152","article-title":"The apolipoprotein E mimetic peptide CN-105 improves outcome in a murine model of SAH","volume":"3","author":"Liu","year":"2018","journal-title":"Stroke and Vasc Neurol"},{"key":"10.1124\/jpet.124.002334_bib20","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1212\/WNL.43.4.712","article-title":"Clinical course of spontaneous subarachnoid hemorrhage: a population-based study in King County, Washington","volume":"43","author":"Longstreth","year":"1993","journal-title":"Neurology"},{"key":"10.1124\/jpet.124.002334_bib21","doi-asserted-by":"crossref","first-page":"1","DOI":"10.5414\/CPP42001","article-title":"Review of NMDA antagonist-induced neurotoxicity and implications for clinical development","volume":"42","author":"Low","year":"2004","journal-title":"Int J Clin Pharmacol Ther"},{"key":"10.1124\/jpet.124.002334_bib22","doi-asserted-by":"crossref","first-page":"3","DOI":"10.2165\/00126839-199901010-00001","article-title":"Neuroprotection in acute ischaemic stroke. Current status and future potential","volume":"1","author":"Lutsep","year":"1999","journal-title":"Drugs R D"},{"key":"10.1124\/jpet.124.002334_bib23","doi-asserted-by":"crossref","first-page":"E4","DOI":"10.3171\/foc.2006.21.3.4","article-title":"Dissociation between vasospasm and functional improvement in a murine model of subarachnoid hemorrhage","volume":"21","author":"Mesis","year":"2006","journal-title":"Neurosurg Focus"},{"key":"10.1124\/jpet.124.002334_bib24","first-page":"737","article-title":"Failure of the competitive N-methyl-D-aspartate antagonist Selfotel (CGS 19755) in the treatment of severe head injury: results of two phase III clinical trials. The Selfotel Investigators","volume":"91","author":"Morris","year":"1999","journal-title":"J\u00a0Neurosurg"},{"key":"10.1124\/jpet.124.002334_bib25","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1038\/3661","article-title":"Phenylethanolamines inhibit NMDA receptors by enhancing proton inhibition","volume":"1","author":"Mott","year":"1998","journal-title":"Nat Neurosci"},{"key":"10.1124\/jpet.124.002334_bib26","first-page":"1623","article-title":"Subarachnoid hemorrhage","volume":"24","author":"Muehlschlegel","year":"2018","journal-title":"Continuum (Minneap Minn)"},{"key":"10.1124\/jpet.124.002334_bib27","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1124\/jpet.120.000370","article-title":"A\u00a0glutamate N-Methyl-d-aspartate (NMDA) receptor subunit 2B-selective inhibitor of NMDA receptor function with enhanced potency at acidic pH and oral bioavailability for clinical use","volume":"379","author":"Myers","year":"2021","journal-title":"J\u00a0Pharmacol Exp Ther"},{"key":"10.1124\/jpet.124.002334_bib28","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1007\/s12975-020-00867-0","article-title":"Aneurysmal subarachnoid hemorrhage: the last decade","volume":"12","author":"Neifert","year":"2021","journal-title":"Transl Stroke Res"},{"key":"10.1124\/jpet.124.002334_bib29","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0304-3940(97)00176-6","article-title":"Influence of extracellular pH on inhibition by ifenprodil at N-methyl-D-aspartate receptors in Xenopus oocytes","volume":"225","author":"Pahk","year":"1997","journal-title":"Neurosci Lett"},{"key":"10.1124\/jpet.124.002334_bib30","doi-asserted-by":"crossref","first-page":"241","DOI":"10.2174\/1389450013348335","article-title":"Neuroprotection by NMDA receptor antagonists in a variety of neuropathologies","volume":"2","author":"Palmer","year":"2001","journal-title":"Curr Drug Targets"},{"key":"10.1124\/jpet.124.002334_bib31","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1179\/016164102101200276","article-title":"Mouse model of subarachnoid hemorrhage associated cerebral vasospasm: methodological analysis","volume":"24","author":"Parra","year":"2002","journal-title":"Neurol Res"},{"key":"10.1124\/jpet.124.002334_bib32","article-title":"The ARRIVE guidelines 20: updated guidelines for reporting animal research","volume":"18","author":"Percie du Sert","year":"2020","journal-title":"PLoS Biol"},{"key":"10.1124\/jpet.124.002334_bib33","first-page":"505","article-title":"Nimodipine treatment in poor-grade aneurysm patients. Results of a multicenter double-blind placebo-controlled trial","volume":"68","author":"Petruk","year":"1988","journal-title":"J\u00a0Neurosurg"},{"key":"10.1124\/jpet.124.002334_bib34","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1136\/bmj.298.6674.636","article-title":"Effect of oral nimodipine on cerebral infarction and outcome after subarachnoid haemorrhage: British aneurysm nimodipine trial","volume":"298","author":"Pickard","year":"1989","journal-title":"BMJ"},{"key":"10.1124\/jpet.124.002334_bib35","doi-asserted-by":"crossref","first-page":"1719","DOI":"10.1001\/jama.285.13.1719","article-title":"Glycine antagonist in neuroprotection for patients with acute stroke: GAIN Americas: a randomized controlled trial","volume":"285","author":"Sacco","year":"2001","journal-title":"JAMA"},{"key":"10.1124\/jpet.124.002334_bib36","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1161\/STROKEAHA.112.671354","article-title":"The 2012 Feinberg Lecture: treatment swift and treatment sure","volume":"44","author":"Saver","year":"2013","journal-title":"Stroke"},{"key":"10.1124\/jpet.124.002334_bib37","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1038\/jcbfm.1992.107","article-title":"Ion homeostasis in rat brain in\u00a0vivo: intra- and extracellular [Ca2+] and [H+] in the hippocampus during recovery from short-term, transient ischemia","volume":"12","author":"Silver","year":"1992","journal-title":"J\u00a0Cereb Blood Flow Metab"},{"key":"10.1124\/jpet.124.002334_bib38","doi-asserted-by":"crossref","first-page":"6445","DOI":"10.1073\/pnas.87.16.6445","article-title":"Modulation of the N-methyl-Daspartate channel by extracellular H+","volume":"87","author":"Tang","year":"1990","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/jpet.124.002334_bib39","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1038\/345347a0","article-title":"Proton inhibition of N-methyl-Daspartate receptors in cerebellar neurons","volume":"345","author":"Traynelis","year":"1990","journal-title":"Nature"},{"key":"10.1124\/jpet.124.002334_bib40","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1113\/jphysiol.1991.sp018453","article-title":"Pharmacological properties and H+ sensitivity of excitatory amino acid receptor channels in rat cerebellar granule neurones","volume":"433","author":"Traynelis","year":"1991","journal-title":"J\u00a0Physiol"},{"key":"10.1124\/jpet.124.002334_bib41","first-page":"978","article-title":"Systematic review of the prevention of delayed ischemic neurological deficits with hypertension, hypervolemia, and hemodilution therapy following subarachnoid hemorrhage","volume":"98","author":"Treggiari","year":"2003","journal-title":"J\u00a0Neurosurg"},{"key":"10.1124\/jpet.124.002334_bib42","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/S0140-6736(07)60153-6","article-title":"Subarachnoid haemorrhage","volume":"369","author":"van Gijn","year":"2007","journal-title":"Lancet"},{"key":"10.1124\/jpet.124.002334_bib43","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1113\/jphysiol.1990.sp018304","article-title":"The effect of external pH changes on responses to excitatory amino acids in mouse hippocampal neurones","volume":"430","author":"Vyklicky","year":"1990","journal-title":"J\u00a0Physiol"},{"key":"10.1124\/jpet.124.002334_bib44","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1007\/s12028-020-01184-y","article-title":"Neuroprotective pentapeptide, CN-105, improves outcomes in translational models of intracerebral hemorrhage","volume":"35","author":"Wang","year":"2021","journal-title":"Neurocrit Care"},{"key":"10.1124\/jpet.124.002334_bib45","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1007\/s12028-013-9944-9","article-title":"pH-sensitive NMDA inhibitors improve outcome in a murine model of SAH","volume":"20","author":"Wang","year":"2014","journal-title":"Neurocrit Care"},{"key":"10.1124\/jpet.124.002334_bib46","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1016\/j.neuron.2015.02.008","article-title":"Context-dependent GluN2B-selective inhibitors of NMDA receptor function are neuroprotective with minimal side effects","volume":"85","author":"Yuan","year":"2015","journal-title":"Neuron"},{"key":"10.1124\/jpet.124.002334_bib47","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1002\/cpdd.1217","article-title":"Phase 1 clinical results for NP10679, a pH-sensitive GluN2B-selective NMDA receptor inhibitor","volume":"12","author":"Zaczek","year":"2023","journal-title":"Clin Pharmacol Drug Dev"}],"container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002235652428695X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002235652428695X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/jpet.124.002334","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,26]],"date-time":"2025-02-26T02:51:23Z","timestamp":1740538283000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S002235652428695X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":45,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,1]]}},"alternative-id":["S002235652428695X"],"URL":"https:\/\/doi.org\/10.1124\/jpet.124.002334","relation":{},"ISSN":["0022-3565"],"issn-type":[{"value":"0022-3565","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical development of the GluN2B-selective NMDA receptor inhibitor NP10679 for the treatment of neurologic deficit after subarachnoid hemorrhage","name":"articletitle","label":"Article Title"},{"value":"The Journal of Pharmacology and Experimental Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/jpet.124.002334","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 American Society for Pharmacology and Experimental Therapeutics. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"100046"}}